Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical Hematology International is Scopus-indexed (Q1, CiteScore 3.4), DOAJ. Published by Saabron Press.
Checked against the index lists dated .
ISSN 2590-0048Verify ISSN ↗
Publisher: Saabron Press
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Health Professions (miscellaneous) | 16 / 101 | 84th | Q1 |
| Hematology | 71 / 151 | 53rd | Q2 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present, best quartile Q1, CiteScore 3.4.
Clinical Hematology International is Q1 in Health Professions (miscellaneous) (rank 16 of 101) and Q2 in Hematology (rank 71 of 151), by CiteScore 2025.
Clinical Hematology International is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 3.4, quartile Q1, 84th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.806, quartile Q1, with an H-index of 11.
Clinical Hematology International is published by Saabron Press. Its ISSN is 2590-0048.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Clinical Hematology International has an h-index of 22 and a 2-year mean of 3.98 citations per paper (OpenAlex). Its Scopus CiteScore is 3.4, quartile Q1. On 2-year citations it ranks #5 of 97 Scopus journals in Health Professions (miscellaneous).
Clinical Hematology International published 27 papers in 2025; its busiest recent year was 2024 with 48. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2023–2026), authors are most often from United States (34.9%), France (13.2%) and United Kingdom (5.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.